A detailed history of Truist Financial Corp transactions in Amarin Corp Plcuk stock. As of the latest transaction made, Truist Financial Corp holds 11,909 shares of AMRN stock, worth $5,835. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11,909
Previous 11,909 -0.0%
Holding current value
$5,835
Previous $8,000 12.5%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 20, 2024

SELL
$0.63 - $1.07 $315 - $535
-500 Reduced 4.03%
11,909 $8,000
Q4 2023

Feb 02, 2024

SELL
$0.66 - $0.91 $47,916 - $66,066
-72,600 Reduced 85.4%
12,409 $10,000
Q3 2023

Nov 14, 2023

BUY
$0.85 - $1.43 $61,710 - $103,818
72,600 Added 585.06%
85,009 $78,000
Q4 2022

Feb 17, 2023

SELL
$1.07 - $1.34 $1,284 - $1,608
-1,200 Reduced 8.82%
12,409 $15,000
Q3 2022

Oct 26, 2022

SELL
$1.09 - $1.67 $3,348 - $5,130
-3,072 Reduced 18.42%
13,609 $15,000
Q2 2022

Jul 22, 2022

SELL
$1.13 - $3.69 $112 - $369
-100 Reduced 0.6%
16,681 $25,000
Q4 2021

Feb 14, 2022

SELL
$3.24 - $5.18 $1,710 - $2,735
-528 Reduced 3.05%
16,781 $57,000
Q3 2021

Nov 05, 2021

BUY
$3.94 - $5.84 $28,702 - $42,544
7,285 Added 72.68%
17,309 $88,000
Q1 2021

May 17, 2021

SELL
$5.03 - $8.8 $7,545 - $13,200
-1,500 Reduced 13.02%
10,024 $62,000
Q4 2020

Feb 18, 2021

BUY
$4.04 - $5.31 $46,556 - $61,192
11,524 New
11,524 $68,000
Q2 2020

Aug 14, 2020

SELL
$4.78 - $8.26 $55,275 - $95,518
-11,564 Closed
0 $0
Q1 2020

May 15, 2020

SELL
$4.0 - $21.53 $29,300 - $157,707
-7,325 Reduced 38.78%
11,564 $46,000
Q4 2019

Feb 14, 2020

BUY
$13.94 - $24.12 $263,312 - $455,602
18,889 New
18,889 $405,000

Others Institutions Holding AMRN

About AMARIN CORP PLCUK


  • Ticker AMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 403,206,016
  • Market Cap $198M
  • Description
  • Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...
More about AMRN
Track This Portfolio

Track Truist Financial Corp Portfolio

Follow Truist Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Truist Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Truist Financial Corp with notifications on news.